[go: up one dir, main page]

BE898819A - OSMOTIC DEVICE - Google Patents

OSMOTIC DEVICE

Info

Publication number
BE898819A
BE898819A BE0/212326A BE212326A BE898819A BE 898819 A BE898819 A BE 898819A BE 0/212326 A BE0/212326 A BE 0/212326A BE 212326 A BE212326 A BE 212326A BE 898819 A BE898819 A BE 898819A
Authority
BE
Belgium
Prior art keywords
osmotic
composition
osmotic device
compartment
surrounds
Prior art date
Application number
BE0/212326A
Other languages
French (fr)
Inventor
P S L Wong
B Barclay
J C Deters
F Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23961585&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BE898819(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Alza Corp filed Critical Alza Corp
Publication of BE898819A publication Critical patent/BE898819A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

On prévoit un dispositif osmotique comprenant une paroi formée au moins en partie d'une matière semi-perméable qui entoure un compartiment, ce compartiment contenant une première composition osmotique comprenant un agent bénéfique, et une seconde composition osmotique différente de la première, une voie de passage dans la paroi reliant la première composition à l'extérieur du dispositif.An osmotic device is provided comprising a wall formed at least in part of a semipermeable material which surrounds a compartment, this compartment containing a first osmotic composition comprising a beneficial agent, and a second osmotic composition different from the first, a pathway passage through the wall connecting the first composition to the outside of the device.

BE0/212326A 1983-05-11 1984-02-02 OSMOTIC DEVICE BE898819A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49376083A 1983-05-11 1983-05-11

Publications (1)

Publication Number Publication Date
BE898819A true BE898819A (en) 1984-05-30

Family

ID=23961585

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212326A BE898819A (en) 1983-05-11 1984-02-02 OSMOTIC DEVICE

Country Status (20)

Country Link
JP (1) JPS6041609A (en)
AT (1) AT397180B (en)
AU (1) AU566110B2 (en)
BE (1) BE898819A (en)
CA (1) CA1222950A (en)
CH (1) CH669329A5 (en)
DE (1) DE3417113A1 (en)
DK (1) DK163910C (en)
ES (1) ES532018A0 (en)
FR (1) FR2545721B1 (en)
GB (1) GB2140687B (en)
IE (1) IE56515B1 (en)
IL (1) IL71727A (en)
IT (1) IT1178911B (en)
MX (1) MX163518B (en)
NL (1) NL192250C (en)
NO (1) NO170834C (en)
NZ (1) NZ206600A (en)
SE (1) SE455918B (en)
ZA (1) ZA842422B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH075457B2 (en) * 1983-08-16 1995-01-25 ザ ウエルカム フアウンデ−シヨン リミテツド Pharmaceutical composition allowing the release of the active ingredient in a controlled manner
US4600773A (en) * 1983-12-01 1986-07-15 Eli Lilly And Company Crystalline cephalexin hydrochloride monohydrate
US4624847A (en) * 1985-04-22 1986-11-25 Alza Corporation Drug delivery device for programmed delivery of beneficial drug
US4963141A (en) * 1985-08-16 1990-10-16 Alza Corporation Dispensing system for administering beneficial agent formulation to ruminants
ES8800043A1 (en) * 1985-08-16 1987-10-16 Alza Corp Osmotic dispenser
US4704118A (en) * 1985-08-16 1987-11-03 Alza Corporation Ruminant dispensing device with thermo-activated memory
US4723957A (en) * 1986-02-07 1988-02-09 Alza Corp. System for delivering drug with enhanced bioacceptability
US4716496A (en) * 1986-05-09 1987-12-29 Eaton Corporation Panel-mounted control station housing
US4814181A (en) * 1987-09-03 1989-03-21 Alza Corporation Dosage form comprising fast agent delivery followed by slow agent delivery
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
DE3871343D1 (en) * 1987-11-25 1992-06-25 American Cyanamid Co SYSTEM FOR THE DELAYED (CONTROLLED) RELEASE OF SUBSTITUTED DIHYDROPYRIDINE CALCIUMANTAGONISTS.
US4837111A (en) * 1988-03-21 1989-06-06 Alza Corporation Dosage form for dispensing drug for human therapy
US4855141A (en) * 1988-03-25 1989-08-08 Alza Corporation Device comprising means for protecting and dispensing fluid sensitive medicament
US4859470A (en) * 1988-06-02 1989-08-22 Alza Corporation Dosage form for delivering diltiazem
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
IL91398A (en) * 1988-08-30 1994-05-30 Pfizer Pharmaceutical delivery device comprising active substance surrounded by asymmetric membrane
GR1000270B (en) * 1988-09-30 1992-05-12 Alza Corp Dose for cardiovascular troubles therapy
US5030452A (en) * 1989-01-12 1991-07-09 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
IL92966A (en) * 1989-01-12 1995-07-31 Pfizer Dispensing devices powered by hydrogel
US5108756A (en) * 1989-01-12 1992-04-28 Pfizer Inc. Dispensing devices powered by lyotropic liquid crystals
EP0408496A3 (en) * 1989-07-12 1992-07-01 Ciba-Geigy Ag Solid dosage form for pharmaceutical substances
US5067960A (en) * 1989-12-06 1991-11-26 Medtronic, Inc. Muscle fitness detection by colorimetry
US5190763A (en) * 1990-05-07 1993-03-02 Alza Corporation Dosage form indicated for the management of abnormal posture, tremor and involuntary movement
US5081161A (en) * 1990-06-15 1992-01-14 E. I. Du Pont De Nemours And Company Process for making shaped articles of a thermoplastic resin having a microcellular structure
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US5166145A (en) * 1990-09-10 1992-11-24 Alza Corporation Antiemetic therapy
DK0550641T3 (en) * 1990-09-28 1994-08-22 Pfizer Dispensing device containing a hydrophobic medium
US5208037A (en) * 1991-04-22 1993-05-04 Alza Corporation Dosage forms comprising polymers comprising different molecular weights
EP0612519B1 (en) * 1993-02-23 2001-04-04 Wolfgang Dr. Werner Use of a calcium formulation in a medicament for therapeutic application to milk cows suffering from hypocalcaemia
US6440457B1 (en) 1993-05-27 2002-08-27 Alza Corporation Method of administering antidepressant dosage form
US6287598B1 (en) * 1993-05-28 2001-09-11 Alza Corporation Method for providing sustained antiepileptic therapy
HU213407B (en) * 1993-12-09 1997-06-30 Egyt Gyogyszervegyeszeti Gyar Process for producing tablet with diffusive-osmotic release
US5460826A (en) * 1994-06-27 1995-10-24 Alza Corporation Morphine therapy
US5948787A (en) 1997-02-28 1999-09-07 Alza Corporation Compositions containing opiate analgesics
DE19962924A1 (en) 1999-12-24 2001-07-05 Bayer Ag Substituted oxazolidinones and their use
US6733783B2 (en) * 2000-10-30 2004-05-11 Euro-Celtique S.A. Controlled release hydrocodone formulations
US20110104214A1 (en) 2004-04-15 2011-05-05 Purdue Pharma L.P. Once-a-day oxycodone formulations
DE10129725A1 (en) 2001-06-20 2003-01-02 Bayer Ag Combination therapy of substituted oxazolidinones
DE10300111A1 (en) 2003-01-07 2004-07-15 Bayer Healthcare Ag Process for the preparation of 5-chloro-N - ({(5S) -2-oxo-3- [4- (3-oxo-4-morpholinyl) phenyl] -1,3-oxazolidin-5-yl} methyl ) -2-thiophenecarboxamide
US10213387B2 (en) 2003-09-19 2019-02-26 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
KR101164881B1 (en) * 2003-09-19 2012-07-23 썬 파마슈티컬 인더스트리스 리미티드 Oral drug delivery system
US10226428B2 (en) 2003-09-19 2019-03-12 Sun Pharma Advanced Research Company Ltd. Oral drug delivery system
DE10355461A1 (en) 2003-11-27 2005-06-23 Bayer Healthcare Ag Solid, high bioavailabilty oral formulations of N-substituted 5-chloro-2-thiophene-carboxamide derivative in hydrophilized form, useful for combating thrombo-embolic diseases
DE102004062475A1 (en) * 2004-12-24 2006-07-06 Bayer Healthcare Ag Solid, orally administrable, modified release pharmaceutical dosage forms
EP1685841A1 (en) 2005-01-31 2006-08-02 Bayer Health Care Aktiengesellschaft Prevention and treatment of thromboembolic disorders
DE102005031577A1 (en) * 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmaceutical dosage forms containing a combination of nifedipine and / or nisoldipine and an angiotensin II antagonist
DE102005045518A1 (en) 2005-09-23 2007-03-29 Bayer Healthcare Ag New 5-thienylaminocarbonylmethyl-oxazolidin-2-one derivatives, useful for treating and preventing thromboembolic disease, are selective inhibitors of coagulation factor Xa
DE102005047561A1 (en) 2005-10-04 2007-04-05 Bayer Healthcare Ag Drug delivery system, useful to treat and/or prevent e.g. thromboembolic disease, comprises 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)-phenyl)-1,3-oxazolidine-5-yl)-methyl)-2-thiophene carboxamide with fast release active substance
PT1934208E (en) 2005-10-04 2011-06-01 Bayer Schering Pharma Ag Novel polymorphous form of 5-chloro-n-({ (5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl)-phenyl]-1,3-oxazolidine-5-yl}-methyl)-2-thiophene carboxamide
DE102008059206A1 (en) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmaceutical dosage form containing nifedipine or nisoldipine and an angiotensin II antagonist and / or a diuretic
WO2010139111A1 (en) * 2009-06-02 2010-12-09 Dow Global Technologies Inc. Sustained release dosage form
DE102011007272A1 (en) 2011-04-13 2012-10-18 Bayer Pharma Aktiengesellschaft Branched 3-phenylpropionic acid derivatives and their use
MX2014013320A (en) 2012-05-07 2015-08-10 Bayer Pharma AG Process for manufacturing a pharmaceutical dosage form comprising nifedipine and candesartan cilexetil.
UY34856A (en) 2012-07-03 2013-12-31 Bayer Pharma AG PHARMACEUTICAL PRESENTATION FORMS CONTAINING 5-CHLORO-N - ({(5S) -2-OXO-3- [4- (3-OXO-4- MORPHOLINYL) -PHENYL] -1,3-OXAZOLIDIN-5-IL} -METIL) -2-THIOFENCARBOXAMIDE
JP5941117B2 (en) * 2014-10-17 2016-06-29 ダウ グローバル テクノロジーズ エルエルシー Sustained release formulation
US10905667B2 (en) 2018-07-24 2021-02-02 Bayer Pharma Aktiengesellschaft Orally administrable modified-release pharmaceutical dosage form
KR20210035235A (en) 2018-07-24 2021-03-31 바이엘 악티엔게젤샤프트 Pharmaceutical dosage forms that can be administered orally and have modified release
CN112469398A (en) 2018-07-24 2021-03-09 拜耳公司 Pharmaceutical dosage form for oral administration with a sustained release effect

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL38538A (en) * 1971-01-13 1974-09-10 Alza Corp Osmotic dispenser
US3977404A (en) * 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4160452A (en) * 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4265874A (en) * 1980-04-25 1981-05-05 Alza Corporation Method of delivering drug with aid of effervescent activity generated in environment of use
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4449983A (en) * 1982-03-22 1984-05-22 Alza Corporation Simultaneous delivery of two drugs from unit delivery device

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4992277A (en) * 1989-08-25 1991-02-12 Schering Corporation Immediate release diltiazem formulation
US5000962A (en) * 1989-08-25 1991-03-19 Schering Corporation Long acting diltiazem formulation

Also Published As

Publication number Publication date
NL192250B (en) 1996-12-02
IT8467283A0 (en) 1984-03-23
ES8503503A1 (en) 1985-03-01
NO170834C (en) 1992-12-16
DK163910C (en) 1992-09-14
FR2545721A1 (en) 1984-11-16
ZA842422B (en) 1984-11-28
AU566110B2 (en) 1987-10-08
GB2140687B (en) 1987-03-18
SE8402512L (en) 1984-11-12
IE56515B1 (en) 1991-08-28
DE3417113A1 (en) 1984-11-15
AU2251183A (en) 1984-11-15
NZ206600A (en) 1987-01-23
ATA88084A (en) 1993-07-15
IL71727A0 (en) 1984-09-30
AT397180B (en) 1994-02-25
CA1222950A (en) 1987-06-16
DK99784A (en) 1984-11-12
DK99784D0 (en) 1984-02-24
GB2140687A (en) 1984-12-05
DE3417113C2 (en) 1989-02-02
FR2545721B1 (en) 1987-11-06
CH669329A5 (en) 1989-03-15
IT8467283A1 (en) 1985-09-23
NL192250C (en) 1997-04-03
ES532018A0 (en) 1985-03-01
IT1178911B (en) 1987-09-16
MX163518B (en) 1992-05-25
SE455918B (en) 1988-08-22
NO170834B (en) 1992-09-07
GB8334189D0 (en) 1984-02-01
SE8402512D0 (en) 1984-05-09
IL71727A (en) 1989-01-31
IE840010L (en) 1984-11-11
DK163910B (en) 1992-04-21
JPS6041609A (en) 1985-03-05
NL8401470A (en) 1984-12-03
NO840248L (en) 1984-11-12
JPH0575725B2 (en) 1993-10-21

Similar Documents

Publication Publication Date Title
BE898819A (en) OSMOTIC DEVICE
BE898820A (en) OSMOTIC DEVICE
ES509706A0 (en) "IMPROVEMENTS INTRODUCED IN THE PURPOSE OF MAIN PATENT N 504.302".
NL186746C (en) FLUID DISPENSER AND MIXING CHAMBER.
IT8221319A0 (en) COMBINATION OF AUTONOMOUS PUMP AND REVERSING MECHANISM FOR THE SAME.
ES508017A0 (en) "IMPROVEMENTS IN DISCHARGE VALVES."
FI850336A7 (en) Ultrasonic flow meter.
TR22099A (en) CAHSAN SUERGUELUE OERTUE KAPAKH TWO BICAKH CARTUS WITH CLEANING FRAGRANCE AND UNION
FR2717099B1 (en) Extraction agent for the selective extraction of strontium from an aqueous solution containing it.
ES513337A0 (en) "MEASURING DEVICE OF THE FLOW RATE AND A FLUID".
NO870810D0 (en) DETERSIVE SYSTEMS AND LOW-FOAMING Aqueous SOLUTIONS OF SURFACTIVE AGENTS.
IT1233521B (en) TURBINE INLET FLOW DETECTOR AND SEALING SYSTEM.
BE891230A (en) ANTISTATIC COMPOSITION AND PHOTOGRAPHIC PRODUCT CONTAINING THE SAME
FR2656927B1 (en) IMMUNOTEST DEVICE OF THE PLUNGE TYPE, AND KIT CONTAINING THIS DEVICE.
BR9106664A (en) CONCENTRATE OF LIQUID SURFACE AGENT, FREE FLOW AND PUMPABLE
ES511945A0 (en) "IMPROVEMENTS INTRODUCED IN THE METAL BAND GALVANIZATION FACILITIES".
FR2541745B1 (en) DEVICE FOR RETAINING A LIQUID PHASE BETWEEN A WALL AND A ROTATING PART THROUGH IT
IT8219444A0 (en) JOINING SYSTEM OF SEPARATE PARTS WITH THE POSSIBILITY OF REPEATEDLY JOINING AND DETACHING THE PARTS THEMSELVES.
ES513855A0 (en) "IMPROVEMENTS IN FLOWMETERS".
FR2549472B1 (en) N- (2-METHYL-2-PENTENOYL) -4'-ISOPROPYL-ANILIDE, ITS PREPARATION AND SELECTIVE HERBICIDE CONTAINING IT
IT1176622B (en) DISSOLUTION OF METALS WITH THE USE OF A PYROLIDONE
IT8419385A0 (en) PERFECTED CAVITY SURROUNDING AN INLET OR OUTLET PIPE OF THE REFRIGERANT OF A NUCLEAR REACTOR.
TR21697A (en) SELECTIVE HERBISID-COMPACTED TIAZOLO AND (1,3) TIAZINO (2,3-C) (1,2,4) TRIAZINONS AND THE MANUFACTURING PROCEDURES OF THESE COMPOUNDS
IT8224851A0 (en) JOINING SYSTEM OF SEPARATE PARTS WITH THE POSSIBILITY OF REPEATEDLY JOINING AND DETACHING THE PARTS THEMSELVES.
ES515197A0 (en) IMPROVEMENTS IN A FLUID DISTRIBUTION MOUTH WITH INDEPENDENT FLOW OF THE PRESSURE.

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: *ALZA CORP.

Effective date: 20040202